A novel dual-epigenetic inhibitor enhances recombinant monoclonal antibody expression in CHO cells
Applied Microbiology and Biotechnology · 2024
DOI: 10.1007/s00253-024-13302-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Microbiology and Biotechnology, 2024. Verfasst von Ming-Ming Han und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Xinxiang Medical University, Xinxiang, 453003, Henan, China. Hauptthemen laut MEDLINE: Cricetulus, Antibodies, Monoclonal, Recombinant Proteins, Epigenesis, Genetic. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Henan Provincial Science and Technology Research Project, Key Research & Development Projects of Henan Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Xinxiang Medical University, Xinxiang, 453003, Henan, China.
- International Joint Research Laboratory for Recombinant Pharmaceutical Protein Expression System of Henan, Xinxiang Medical University, Xinxiang, 453003, Henan, China.
- Henan Engineering Research Center for Biopharmaceutical Innovation, Xinxiang Medical University, Xinxiang, 453003, Henan, China.
- Junji College, Xinxiang Medical University, Xinxiang, 453003, Henan, China.
- School of Basic Medicine, Xinxiang Medical University, Xinxiang, 453003, Henan, China.
- International Joint Research Laboratory for Recombinant Pharmaceutical Protein Expression System of Henan, Xinxiang Medical University, Xinxiang, 453003, Henan, China. wtianyuncn@126.com.
Förderung
- National Natural Science Foundation of China
- Henan Provincial Science and Technology Research Project
- Key Research & Development Projects of Henan Province
- Project of Technology Innovation Leading Talent in Central Plain
- Natural Science Foundation of Henan Province
- the National Training Program of Innovation and Entrepreneurship for Undergraduates of Xinxiang Medical University
Zitieren
APA
Han, M. M., Wang, H. T., Zhang, H. J., Lu, J. T., Guo, J. L., Qiu, L. L., Zhang, X., Wang, X. Y., Wang, T. Y., & Jia, Y. L. (2024). A novel dual-epigenetic inhibitor enhances recombinant monoclonal antibody expression in CHO cells. Applied Microbiology and Biotechnology. https://doi.org/10.1007/s00253-024-13302-3
Vancouver
Han MM, Wang HT, Zhang HJ, Lu JT, Guo JL, Qiu LL, et al. A novel dual-epigenetic inhibitor enhances recombinant monoclonal antibody expression in CHO cells. Applied Microbiology and Biotechnology. 2024. doi:10.1007/s00253-024-13302-3
BibTeX
@article{Han2024,
author = {Han, Ming-Ming and Wang, Hai-Tong and Zhang, Hui-Jie and Lu, Jiang-Tao and Guo, Jia-Liang and Qiu, Le-Le and Zhang, Xi and Wang, Xiao-Yin and Wang, Tian-Yun and Jia, Yan-Long},
title = {A novel dual-epigenetic inhibitor enhances recombinant monoclonal antibody expression in CHO cells},
journal = {Applied Microbiology and Biotechnology},
year = {2024},
doi = {10.1007/s00253-024-13302-3}
}
EUVIMED